Skip to main content
Top
Published in: BMC Dermatology 1/2005

Open Access 01-12-2005 | Research article

Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients

Authors: Hassan Seyrafi, Maryam Akhiani, Hamed Abbasi, Sahar Mirpour, Ali Gholamrezanezhad

Published in: BMC Dermatology | Issue 1/2005

Login to get access

Abstract

Background

The study aimed at evaluating the prevalence of thyroid function abnormalities in patients with alopecia areata (AA) and its association with other autoimmune diseases and various autoimmune antibodies.

Method

We retrospectively analyzed medical records of 123 patients with AA. The main site of involvement, pattern, and extent of alopecia as well as presence of the similar disease in first-degree family members and serologic status of patients were recorded.

Results

Participating in the study were 57 males and 66 females (6 to 59 years old). In the majority of patients (69.9%) the disease was manifested in the first two decades of life. Patients with family members having alopecia were recorded in 24.4%. Thyroid function abnormalities were found in 8.9% of patients. Positive autoimmune antibodies were associated with AA in 51.4% of patients with no significant association between the severity and duration of disease and presence of these antibodies.

Conclusion

The incidence of positive auto-immune antibodies in Iranian patients is higher than previous reports. Concerning the female:male ratio, thyroid function tests and the prevalence of alopecia in first-degree relatives, our results are compatible with previous data obtained from different ethnic populations. Previous reports documented that a greater severity and longer duration of AA were seen in the early onset forms; however our result are relatively different which could be explained by differences in genetic factors.
Literature
1.
go back to reference Hedstrand H, Perheentupa J, Ekwall O, Gustafsson J, Michaelsson G, Husebye E, Rorsman F, Kampe O: Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I. J Invest Dermatol 1999, 113: 1054–8. 10.1046/j.1523-1747.1999.00778.xCrossRefPubMed Hedstrand H, Perheentupa J, Ekwall O, Gustafsson J, Michaelsson G, Husebye E, Rorsman F, Kampe O: Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I. J Invest Dermatol 1999, 113: 1054–8. 10.1046/j.1523-1747.1999.00778.xCrossRefPubMed
2.
go back to reference Roselino AM, Almeida AM, Hippolito MA, Cerqueira BC, Maffei CM, Menezes JB, Vieira RE, Assis SL, Ali SA: Clinical epidemiologic study of alopecia areata. Int J Dermatol 1996,35(3):181–4.CrossRefPubMed Roselino AM, Almeida AM, Hippolito MA, Cerqueira BC, Maffei CM, Menezes JB, Vieira RE, Assis SL, Ali SA: Clinical epidemiologic study of alopecia areata. Int J Dermatol 1996,35(3):181–4.CrossRefPubMed
3.
go back to reference Shellow WV, Edwards JE, Koo JY: Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol 1992,31(3):186–9.CrossRefPubMed Shellow WV, Edwards JE, Koo JY: Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol 1992,31(3):186–9.CrossRefPubMed
4.
go back to reference Milgraum SS, Mitchell AJ, Bacon GE, Rasmussen JE: Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. J Am acad Dermatol 1987, 17: 57–61.CrossRefPubMed Milgraum SS, Mitchell AJ, Bacon GE, Rasmussen JE: Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. J Am acad Dermatol 1987, 17: 57–61.CrossRefPubMed
5.
go back to reference Friedman PS: Alopecia areata and autoimmunity. Br J Dermatol 1969, 81;105: 153–7. Friedman PS: Alopecia areata and autoimmunity. Br J Dermatol 1969, 81;105: 153–7.
6.
go back to reference Sharma VK, Dawn G, Kumar B: Profile of alopecia areata in Northern India. Int J Dermatol 1996,35(1):22–7.CrossRefPubMed Sharma VK, Dawn G, Kumar B: Profile of alopecia areata in Northern India. Int J Dermatol 1996,35(1):22–7.CrossRefPubMed
7.
go back to reference Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S: Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 1994,33(9):632–3.CrossRefPubMed Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S: Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 1994,33(9):632–3.CrossRefPubMed
8.
go back to reference Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, Stenn K: Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 1999,40(2 Pt 1):242–6.CrossRefPubMed Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, Stenn K: Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 1999,40(2 Pt 1):242–6.CrossRefPubMed
9.
go back to reference Ebel B: The papyrous Ebers. In The greatest Egyptian medical document. Copenhage: Leivin and Munksgaard; 1937. Ebel B: The papyrous Ebers. In The greatest Egyptian medical document. Copenhage: Leivin and Munksgaard; 1937.
10.
go back to reference Nanda A, Alsaleh QA, Al-Hasawi F, Al-Muzairai I: Thyroid function, autoantibodies, and HLA tissue typing in children with alopecia areata. Pediatr Dermatol 2002,19(6):486–91. 10.1046/j.1525-1470.2002.00216.xCrossRefPubMed Nanda A, Alsaleh QA, Al-Hasawi F, Al-Muzairai I: Thyroid function, autoantibodies, and HLA tissue typing in children with alopecia areata. Pediatr Dermatol 2002,19(6):486–91. 10.1046/j.1525-1470.2002.00216.xCrossRefPubMed
11.
go back to reference Anderson I: Alopecia areata: a clinical study. Br Med J 1950, 4691: 1250–2.CrossRef Anderson I: Alopecia areata: a clinical study. Br Med J 1950, 4691: 1250–2.CrossRef
12.
go back to reference Muller SA, Winkelmann RK: Alopecia areata. An evaluation of 736 patients. Arch Dermatol 1963, 88: 290–7.CrossRefPubMed Muller SA, Winkelmann RK: Alopecia areata. An evaluation of 736 patients. Arch Dermatol 1963, 88: 290–7.CrossRefPubMed
13.
go back to reference De Weert J, Temmerman L, Kint A: Alopecia areata: a clinical study. Dermatologica 1984,168(5):224–9.CrossRefPubMed De Weert J, Temmerman L, Kint A: Alopecia areata: a clinical study. Dermatologica 1984,168(5):224–9.CrossRefPubMed
14.
go back to reference De Waard-van der Spek FB, Oranje AP, De Raeymaecker DM, Peereboom-Wynia JD: Juvenile versus maturity-onset alopecia areata-a comparative retrospective clinical study. Clin Exp Dermatol 1989,14(6):429–33.CrossRefPubMed De Waard-van der Spek FB, Oranje AP, De Raeymaecker DM, Peereboom-Wynia JD: Juvenile versus maturity-onset alopecia areata-a comparative retrospective clinical study. Clin Exp Dermatol 1989,14(6):429–33.CrossRefPubMed
15.
go back to reference Switzer SE: Alopecia areata in an infant. Arch Dermatol Syphilol 1947, 55: 143–5.CrossRef Switzer SE: Alopecia areata in an infant. Arch Dermatol Syphilol 1947, 55: 143–5.CrossRef
16.
go back to reference Vinod K, Sharma VK, Goutan D, Bhushan K: Profile of alopecia areata in northern India. Int J Dermatol 1996,35(1):22–7. Vinod K, Sharma VK, Goutan D, Bhushan K: Profile of alopecia areata in northern India. Int J Dermatol 1996,35(1):22–7.
17.
go back to reference Tobin DJ, Orentreich N, Fenton DA, Bystryn JC: Antibodies to hair follicles in alopecia areata. J Invest Dermatol 1994,102(5):721–4. 10.1111/1523-1747.ep12375477CrossRefPubMed Tobin DJ, Orentreich N, Fenton DA, Bystryn JC: Antibodies to hair follicles in alopecia areata. J Invest Dermatol 1994,102(5):721–4. 10.1111/1523-1747.ep12375477CrossRefPubMed
18.
go back to reference Lewinski A, Broniarczyk-Dyla G, Sewerynek E, Zerek-Melen G, Szkudlinski M: Abnormalities in structure and function of the thyroid gland in patients with alopecia areata. J Am Acad Dermatol 1990,23(4 Pt 1):768–9.CrossRefPubMed Lewinski A, Broniarczyk-Dyla G, Sewerynek E, Zerek-Melen G, Szkudlinski M: Abnormalities in structure and function of the thyroid gland in patients with alopecia areata. J Am Acad Dermatol 1990,23(4 Pt 1):768–9.CrossRefPubMed
19.
go back to reference Heydarian P, Azizi F: Thyroid dysfunction and autoantibodies 10 years after implementation of universal salt iodization: Tehran Thyroid Study. Irn J Endcorinol Metab 2003,4(4):229–41. Heydarian P, Azizi F: Thyroid dysfunction and autoantibodies 10 years after implementation of universal salt iodization: Tehran Thyroid Study. Irn J Endcorinol Metab 2003,4(4):229–41.
20.
go back to reference Sharma VK, Sialy R, Kumar B, Gupta S: Evaluation of thyroid function in north Indians with alopecia areata: response to intravenous injection of 100 micrograms thyrotropin releasing hormone (TRH). J Dermatol 1999,26(6):339–42. 10.1159/000053516CrossRefPubMed Sharma VK, Sialy R, Kumar B, Gupta S: Evaluation of thyroid function in north Indians with alopecia areata: response to intravenous injection of 100 micrograms thyrotropin releasing hormone (TRH). J Dermatol 1999,26(6):339–42. 10.1159/000053516CrossRefPubMed
21.
go back to reference Kumar B, Sharma VK, Sehgal S: Antismooth muscle and antiparietal cell antibodies in Indians with alopecia areata. Int J Dermatol 1995,34(8):542–5.CrossRefPubMed Kumar B, Sharma VK, Sehgal S: Antismooth muscle and antiparietal cell antibodies in Indians with alopecia areata. Int J Dermatol 1995,34(8):542–5.CrossRefPubMed
22.
go back to reference Okamoto M, Ogawa Y, Watanabe A, Sugiura K, Shimomura Y, Aoki N, Nagasaka T, Tomita Y, Muro Y: Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J Autoimmun 2004,23(3):257–66. 10.1016/j.jaut.2004.07.004CrossRefPubMed Okamoto M, Ogawa Y, Watanabe A, Sugiura K, Shimomura Y, Aoki N, Nagasaka T, Tomita Y, Muro Y: Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J Autoimmun 2004,23(3):257–66. 10.1016/j.jaut.2004.07.004CrossRefPubMed
Metadata
Title
Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients
Authors
Hassan Seyrafi
Maryam Akhiani
Hamed Abbasi
Sahar Mirpour
Ali Gholamrezanezhad
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Dermatology / Issue 1/2005
Electronic ISSN: 1471-5945
DOI
https://doi.org/10.1186/1471-5945-5-11

Other articles of this Issue 1/2005

BMC Dermatology 1/2005 Go to the issue